Now in its third year, the company is growing the successful Become A Skin Checker campaign to help prevent and fight skin cancer.
MONTREAL, June 29, 2017 /CNW/ - Today, La Roche-Posay is launching the third edition of the successful Become A Skin Checker campaign. Throughout the summer, the company will help raise awareness of melanoma and other types of skin cancer, and encourage early detection and prevention through self-exams and their Check, Protect, and Play Safe program. Although 90 per cent of skin cancers are curable if detected early, two out of three Canadians have never had a mole checked by a dermatologist.1 In its third year, the campaign is even more committed to providing better access to information on how to adopt safe sun habits through its dedicated platform and its revolutionary wearable technology, My UV Patch.
My UV patch is a unique transparent adhesive containing photosensitive dyes that change color when exposed to UV rays to indicate varying levels of sun exposure. Ultra-thin, ultra-water resistant and adapted to sensitive skin, it can be worn on the back of the hand or another exposed area for up to three days. It offers the comfort of a supple, second-skin device so users can peel, stick and forget it. Users can sleep, shower or swim while wearing the device - and apply their sun protection over it.
With My UV Patch, sun exposure is monitored in real time with perfect comfort and tolerance while offering an engaging augmented reality experience for the user. Users scan the patch using the My UV Patch mobile app, which analyzes the varying photosensitive dye squares to determine the UV exposure level. Through a smart algorithm factoring in the user's personal data – phototype, skin type, location and weather – My UV Patch provides essential information:
- Advice on sun-safe behaviour
- When to re-apply sunscreen
- And even the ideal ANTHELIOS product (including SPF level).
The regular use of My UV Patch has recently demonstrated positive behaviour change, with preliminary survey results showing that the patch use actually improves sun safer behaviour and helps minimize sunburn among users2:
- 63% experienced less sunburn
- 37% used more facial sunscreen
- 31% tried to stay in the shade more
Become a Skin Checker was first launched in 2015 to raise awareness of skin cancer and to educate consumers about how they can protect themselves and their loved ones. Six out of ten Canadians1 say they care more about the health of a loved one than their own, so the Become a Skin Checker initiative is using that insight to ask Canadians to play an active role in protecting friends and family by learning how to detect suspicious moles.
Skin cancer is a growing global epidemic. In 2015, an estimated 6,800 Canadians were diagnosed with melanoma, an easily preventable but potentially deadly disease. And yet, saving your skin can be simple with these three easy steps:
As a pioneering sun care brand for over 30 years and the most recommended brand by dermatologists in Canada, La Roche-Posay has made its mission to raise public awareness regarding sun exposure and skin cancer risks through unique initiatives and smart high-tech innovations to help people stay safe in the sun.
La Roche-Posay will distribute 20,000 UV patches in drugstores and online, including a free online giveaway of 10,000 UV patches in July.
La Roche-Posay invites Canadians to check its dedicated platform to learn more on how they can become skin checkers, the ABCDE method and where they can get a UV patch.
ABOUT LA ROCHE-POSAY
La Roche-Posay is a division of L'Oréal Canada, a wholly-owned subsidiary of L'Oréal Group, the largest cosmetics company in the world. Headquartered in Montreal, L'Oréal Canada had sales of $1.07 billion in 2014 and employs more than 1,200 people. The company's prestigious portfolio of 35 brands encompasses all aspects of beauty.
Through the La Roche-Posay Foundation, under the aegis of the Fondation de France, the brand has been actively supporting research in the clinical, biological and pharmacological fields of dermatology as well as supporting and encouraging generous initiatives from dermatologists.
1 Ipsos 2015
2 Ipsos 2016
SOURCE La Roche-Posay
For further information: Fontane Choi, The Colony Project on behalf of La Roche-Posay, T: (416) 306-6739, E: email@example.com